NTRK1 and non-small cell lung carcinoma: The receptor tyrosine kinase, MET, is one of the most commonly dysregulated oncogenes in non-small cell lung cancer (NSCLC) and met gene amplification has been shown to be a major mechanism in which cancers develop resistance to EGFR inhibitors (Bean et al. 2007).